Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
CureVac (CVAC)
NASDAQ:CVAC
CureVac (CVAC) Stock Price & Analysis
989 Followers
CVAC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.63 - $15.62
Previous Close$9.71
Volume497.59K
Average Volume (3M)502.50K
Market Cap
$2.17B
Enterprise Value$1.72B
Total Cash (Recent Filing)€495.80M
Total Debt (Recent Filing)€42.09M
Price to Earnings (P/E)-7.2
Beta1.48
Next Earnings
Aug 16, 2023EPS Estimate
-$0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.34
Shares Outstanding194,950,000
10 Day Avg. Volume443,155
30 Day Avg. Volume502,496
Standard Deviation0.32
R-Squared0.22
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)4.05
Price to Sales (P/S)28.08
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$17.80Price Target Upside83.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
CureVac News
Pre-EarningsCurevac N.V. (CVAC) Q4 Earnings Cheat Sheet
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CVAC FAQ
What was CureVac’s price range in the past 12 months?
CureVac lowest stock price was $5.63 and its highest was $15.62 in the past 12 months.
What is CureVac’s market cap?
Currently, no data Available
When is CureVac’s upcoming earnings report date?
CureVac’s upcoming earnings report date is Aug 16, 2023 which is in 67 days.
How were CureVac’s earnings last quarter?
Currently, no data Available
Is CureVac overvalued?
According to Wall Street analysts CureVac’s price is currently Undervalued.
Does CureVac pay dividends?
CureVac does not currently pay dividends.
What is CureVac’s EPS estimate?
CureVac’s EPS estimate is -$0.31.
How many shares outstanding does CureVac have?
CureVac has 223,841,550 shares outstanding.
What happened to CureVac’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CureVac?
Among the largest hedge funds holding CureVac’s share is RA Capital Management. It holds CureVac’s shares valued at 85M.
---
CureVac Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
CureVac
CureVac BV a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. The company's product portfolio includes clinical and preclinical candidates across multiple disease indications in oncology, prophylactic vaccines and protein therapy. Its clinical programs are CV8102, which it is evaluating in a Phase 1 clinical trial for the treatment of four types of solid tumors, and CV7202, which it is investigating in a Phase 1 clinical trial for potential vaccination against rabies. It is also rapidly advancing its mRNA vaccine program against coronavirus SARS- CoV-2), for which the company initiated a Phase 1 clinical trial.
---
Top 5 ETFs holding CVAC
iShares NASDAQ US Biotechnology UCITS ETF
$1.11M
Fidelity Nasdaq Composite Index ETF
$374.26K
Vanguard ESG U.S. Stock ETF
$118.17K
Invesco Nasdaq Biotechnology ETF
$41.02K
Vanguard ESG North America All Cap UCITS ETF USD
$1.05K
Up to five ETFs with an Outperform Smart Score that hold CVAC. The ETFs are listed according to market value of CVAC within the ETF
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---